|
| 36346321 | Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data. | Sci Transl Med | 2023 |
| 36174717 | The p300/CBP Inhibitor A485 Normalizes Psoriatic Fibroblast Gene Expression In Vitro and Reduces Psoriasis-Like Skin Inflammation In Vivo. | J Invest Dermatol | 2023 |
| 36346321 | Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data. | Sci Transl Med | 2023 |
| 37602975 | Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channel. | Mol Syst Biol | 2023 |
| 37747367 | Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma. | Oncotarget | 2023 |
| 37568633 | Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma. | Cancers (Basel) | 2023 |
| 37563418 | Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma. | Commun Biol | 2023 |
| 37474523 | Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. | Nat Commun | 2023 |
| 37208128 | Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma. | J Immunother Cancer | 2023 |
| 37207151 | Educational level-dependent melanoma awareness in a high-risk population in Switzerland. | Front Oncol | 2023 |
| 36765834 | P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma. | Cancers (Basel) | 2023 |
| 36638181 | Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. | Sci Adv | 2023 |
| 37453242 | Diagnostic performance of augmented intelligence with 2DÂ and 3DÂ total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening? | Eur J Cancer | 2023 |
| 37071397 | MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production. | Mol Cancer Res | 2023 |
| 36693381 | Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors. | Med | 2023 |
| 37304281 | Investigating the tumor-immune microenvironment through extracellular vesicles from frozen patient biopsies and 3D cultures. | Front Immunol | 2023 |
| 37487833 | EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy. | J Am Acad Dermatol | 2023 |
| 37421613 | Isolation and detection of extracellular vesicles from melanoma cells and liquid biopsies using size-exclusion chromatography and nano-flow cytometry. | STAR Protoc | 2023 |
| 37220897 | gExcite: a start-to-end framework for single-cell gene expression, hashing, and antibody analysis. | Bioinformatics | 2023 |
| 36914141 | Phase-specific signatures of wound fibroblasts and matrix patterns define cancer-associated fibroblast subtypes. | Matrix Biol | 2023 |
| 36785973 | The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. | J Eur Acad Dermatol Venereol | 2023 |
| 36527482 | Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients. | J Cancer Res Clin Oncol | 2023 |
| 37487833 | EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy. | J Am Acad Dermatol | 2023 |
| 37747367 | Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma. | Oncotarget | 2023 |
| 37568633 | Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma. | Cancers (Basel) | 2023 |
| 37602975 | Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channel. | Mol Syst Biol | 2023 |
| 37563418 | Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma. | Commun Biol | 2023 |
| 37220897 | gExcite: a start-to-end framework for single-cell gene expression, hashing, and antibody analysis. | Bioinformatics | 2023 |
| 37421613 | Isolation and detection of extracellular vesicles from melanoma cells and liquid biopsies using size-exclusion chromatography and nano-flow cytometry. | STAR Protoc | 2023 |
| 37453242 | Diagnostic performance of augmented intelligence with 2DÂ and 3DÂ total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening? | Eur J Cancer | 2023 |
| 37208128 | Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma. | J Immunother Cancer | 2023 |
| 37207151 | Educational level-dependent melanoma awareness in a high-risk population in Switzerland. | Front Oncol | 2023 |
| 37304281 | Investigating the tumor-immune microenvironment through extracellular vesicles from frozen patient biopsies and 3D cultures. | Front Immunol | 2023 |
| 37071397 | MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production. | Mol Cancer Res | 2023 |
| 37474523 | Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. | Nat Commun | 2023 |
| 36785973 | The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. | J Eur Acad Dermatol Venereol | 2023 |
| 36693381 | Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors. | Med | 2023 |
| 36914141 | Phase-specific signatures of wound fibroblasts and matrix patterns define cancer-associated fibroblast subtypes. | Matrix Biol | 2023 |
| 36765834 | P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma. | Cancers (Basel) | 2023 |
| 36638181 | Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. | Sci Adv | 2023 |
| 36527482 | Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients. | J Cancer Res Clin Oncol | 2023 |
| 36174717 | The p300/CBP Inhibitor A485 Normalizes Psoriatic Fibroblast Gene Expression In Vitro and Reduces Psoriasis-Like Skin Inflammation In Vivo. | J Invest Dermatol | 2023 |
| 34157151 | Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients. | Allergy | 2022 |
| 36307545 | Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq. | Commun Biol | 2022 |
| 36230498 | Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study. | Cancers (Basel) | 2022 |
| 35954491 | Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception. | Cancers (Basel) | 2022 |
| 35573685 | An Optimized Tissue Dissociation Protocol for Single-Cell RNA Sequencing Analysis of Fresh and Cultured Human Skin Biopsies. | Front Cell Dev Biol | 2022 |
| 35693944 | Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation. | Front Cell Dev Biol | 2022 |
| 36077695 | The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma. | Cancers (Basel) | 2022 |
| 35688559 | Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. | J Immunother Cancer | 2022 |